Pharma Government Investigations

Translate this page Share this page Print this page
Business Litigation
Emerging Companies
FDA & Life Sciences
Government Advocacy
Government Investigations
Intellectual Property
International Arbitration
Labor & Employment
Products Liability/Mass Tort


Healthcare Industry
Overview| People| Matters| News & Insights

King & Spalding’s Special Matters and Government Investigations Group includes more than a dozen former federal prosecutors, congressional investigators and other enforcement officials, as well as lawyers who have devoted their entire careers to white-collar criminal defense, congressional investigations and related civil and qui tam litigation. Our core team of partners and associates has handled all variety of criminal and civil pharmaceutical and device-related investigations by regulators. From high-profile fraud and abuse criminal matters to private, internal corporate compliance issues, our approach is uniquely tailored to each client and each set of facts. Whether the case requires a delicate, cooperative interaction with regulators or an aggressive litigation stance during a federal or state trial, our team is prepared to vigorously defend our client’s interests.

These internal inquiries and civil and criminal investigations by federal and state authorities often involve both bet-the-company issues and significant collateral proceedings, including congressional oversight activities, product liability actions, third-party payor suits, and FDA regulatory actions. Our Special Matters attorneys work closely with our government advocacy & public policy, business litigation, products liability/mass tort and FDA & life sciences regulatory groups to provide multi-disciplinary representation.

Our lawyers understand the investigative process because they themselves prosecuted and defended cases in the government. They learned by doing, and they bring that same insight to bear when counseling our clients in times of crisis. Many of our attorneys served in key positions within the U.S. Department of Justice (DOJ), other regulatory enforcement agencies, and Congressional investigative committees.

In addition to specialized expertise in the life sciences and healthcare industries, the Group handles investigations covering a wide variety of other subject matters, such as the Foreign Corrupt Practices Act (FCPA), SEC and accounting rules, tax controversies, environmental cases and antitrust matters. Our expertise is global, and we have conducted our reviews in countries around the world.

Christopher A Wray (Chris) 
T: +1 202 626 5570 WASHINGTON, D.C.
T: +1 404 572 3544 ATLANTA
T: +1 212 556 2163 NEW YORK